Tigecycline resistance caused by rpsJ evolution in a 59-year-old male patient infected with KPC-producing Klebsiella pneumoniae during tigecycline treatment

Infection, Genetics and Evolution

Volumn 66, Issue , 2018, Pages 188-191

  He, Fang ^a   Shi, Qiucheng ^b   Fu, Ying ^b   Xu, Juan ^c   Yu, Yunsong ^b   Du, Xiaoxing ^b  

^a PEOPLE S HOSPITAL OF HANGZHOU MEDICAL COLLEGE   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Abdominal infection; KPC 2 producing Klebsiella pneumonia; rpsJ; Tigecycline resistance

Indexed keywords

LEUCINE; TIGECYCLINE; VALINE; ANTIINFECTIVE AGENT; BETA LACTAMASE; RIBOSOME PROTEIN;

ADULT; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL GENOME; BACTERIUM ISOLATE; BIOINFORMATICS; CASE REPORT; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MONITORING; EVOLUTION; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; KLEBSIELLA PNEUMONIAE INFECTION; MALE; MIDDLE AGED; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; RPSJ GENE; WHOLE GENOME SEQUENCING; BIOSYNTHESIS; GENETICS; KLEBSIELLA INFECTION; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOLECULAR EVOLUTION;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; EVOLUTION, MOLECULAR; GENOME, BACTERIAL; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RIBOSOMAL PROTEINS; TIGECYCLINE;

EID: 85054601564     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2018.09.025     Document Type: Article

References (25)

1. Beabout, K., Hammerstrom, T.G., Perez, A.M., Magalhaes, B.F., Prater, A.G., Clements, T.P., Arias, C.A., Saxer, G., Shamoo, Y., The ribosomal S10 protein is a general target for decreased tigecycline susceptibility. Antimicrob. Agents Chemother. 59 (2015), 5561–5566.
2. Bratu, S., Landman, D., George, A., Salvani, J., Quale, J., Correlation of the expression of acrB and the regulatory genes marA, soxS and ramA with antimicrobial resistance in clinical isolates of Klebsiella pneumoniae endemic to New York City. J. Antimicrob. Chemother. 64 (2009), 278–283.
3. Cannatelli, A., Giani, T., D'Andrea, M.M., Di Pilato, V., Arena, F., Conte, V., Tryfinopoulou, K., Vatopoulos, A., Rossolini, G.M., MgrB inactivation is a common mechanism of colistin resistance in KPC-producing Klebsiella pneumoniae of clinical origin. Antimicrob. Agents Chemother. 58 (2014), 5696–5703.
4. Chiu, S.K., Huang, L.Y., Chen, H., Tsai, Y.K., Liou, C.H., Lin, J.C., Siu, L.K., Chang, F.Y., Yeh, K.M., Roles of ramR and tet(A) mutations in conferring tigecycline resistance in carbapenem-resistant Klebsiella pneumoniae clinical isolates. Antimicrob. Agents Chemother., 61, 2017 e00391-17.
5. Cunha, B.A., Baron, J., Cunha, C.B., Monotherapy with high-dose once-daily tigecycline is highly effective against acinetobacter baumanii and other multidrug-resistant (MDR) gram-negative bacilli (GNB). Int. J. Antimicrob. Agents 52 (2018), 119–120.
6. Du, X., He, F., Shi, Q., Zhao, F., Xu, J., Fu, Y., Yu, Y., The rapid emergence of tigecycline resistance in blaKPC-2 harboring klebsiella pneumoniae, as mediated in vivo by mutation in teta during tigecycline treatment. Front. Microbiol., 9, 2018, 648.
7. He, F., Fu, Y., Chen, Q., Ruan, Z., Hua, X., Zhou, H., Yu, Y., Tigecycline susceptibility and the role of efflux pumps in tigecycline resistance in KPC-producing Klebsiella pneumoniae. PLoS One, 10, 2015, e0119064.
8. Jenner, L., Starosta, A.L., Terry, D.S., Mikolajka, A., Filonava, L., Yusupov, M., Blanchard, S.C., Wilson, D.N., Yusupova, G., Structural basis for potent inhibitory activity of the antibiotic tigecycline during protein synthesis. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 3812–3816.
9. Linkevicius, M., Sandegren, L., Andersson, D.I., Potential of tetracycline resistance proteins to evolve tigecycline resistance. Antimicrob. Agents Chemother. 60 (2016), 789–796.
10. Osei Sekyere, J., Govinden, U., Bester, L.A., Essack, S.Y., Colistin and tigecycline resistance in carbapenemase-producing Gram-negative bacteria: emerging resistance mechanisms and detection methods. J. Appl. Microbiol. 121 (2016), 601–617.
11. Pankey, G.A., Tigecycline. J. Antimicrob. Chemother. 56 (2005), 470–480.
12. Pitout, J.D., Nordmann, P., Poirel, L., Carbapenemase-producing klebsiella pneumoniae, a key pathogen set for global nosocomial dominance. Antimicrob. Agents Chemother. 59 (2015), 5873–5884.
13. Rodriguez-Avial, C., Rodriguez-Avial, I., Merino, P., Picazo, J.J., Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant patient. Clinical microbiology and infection: the official publication of the. Eur. Soc. Clin. Microbiol. Infect. Dis. 18 (2012), 61–66.
14. Roy, S., Datta, S., Viswanathan, R., Singh, A.K., Basu, S., Tigecycline susceptibility in Klebsiella pneumoniae and Escherichia coli causing neonatal septicaemia (2007-10) and role of an efflux pump in tigecycline non-susceptibility. J. Antimicrob. Chemother. 68 (2013), 1036–1042.
15. Ruan, Z., Feng, Y., BacWGSTdb, a database for genotyping and source tracking bacterial pathogens. Nucleic Acids Res. 44 (2016), D682–D687.
16. Ruzin, A., Visalli, M.A., Keeney, D., Bradford, P.A., Influence of transcriptional activator RamA on expression of multidrug efflux pump AcrAB and tigecycline susceptibility in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 49 (2005), 1017–1022.
17. Ruzin, A., Immermann, F.W., Bradford, P.A., Real-time PCR and statistical analyses of acrAB and ramA expression in clinical isolates of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 52 (2008), 3430–3432.
18. da Silva, R.M., Traebert, J., Galato, D., Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae: a review of epidemiological and clinical aspects. Expert. Opin. Biol. Ther. 12 (2012), 663–671.
19. Sun, Y., Cai, Y., Liu, X., Bai, N., Liang, B., Wang, R., The emergence of clinical resistance to tigecycline. Int. J. Antimicrob. Agents 41 (2013), 110–116.
20. Tumbarello, M., Trecarichi, E.M., De Rosa, F.G., Giannella, M., Giacobbe, D.R., Bassetti, M., Losito, A.R., Bartoletti, M., Del Bono, V., Corcione, S., Maiuro, G., Tedeschi, S., Celani, L., Cardellino, C.S., Spanu, T., Marchese, A., Ambretti, S., Cauda, R., Viscoli, C., Viale, P., Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study. J. Antimicrob. Chemother. 70 (2015), 2133–2143.
21. Veleba, M., Schneiders, T., Tigecycline resistance can occur independently of the ramA gene in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 56 (2012), 4466–4467.
22. Veleba, M., Higgins, P.G., Gonzalez, G., Seifert, H., Schneiders, T., Characterization of RarA, a novel AraC family multidrug resistance regulator in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 56 (2012), 4450–4458.
23. Villa, L., Feudi, C., Fortini, D., Garcia-Fernandez, A., Carattoli, A., Genomics of KPC-producing Klebsiella pneumoniae sequence type 512 clone highlights the role of RamR and ribosomal S10 protein mutations in conferring tigecycline resistance. Antimicrob. Agents Chemother. 58 (2014), 1707–1712.
24. Zankari, E., Hasman, H., Cosentino, S., Vestergaard, M., Rasmussen, S., Lund, O., Aarestrup, F.M., Larsen, M.V., Identification of acquired antimicrobial resistance genes. J. Antimicrob. Chemother. 67 (2012), 2640–2644.
25. Zhang, R., Liu, L., Zhou, H., Chan, E.W., Li, J., Fang, Y., Li, Y., Liao, K., Chen, S., Nationwide Surveillance of Clinical Carbapenem-resistant Enterobacteriaceae (CRE) Strains in China. EBioMedicine 19 (2017), 98–106.